Xiyuan Guo

Luzhou Key Laboratory Of Oral & Maxillofacial Reconstruction And Regeneration
Luzhou, 646000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Flavonoids of Cuscuta chinensis Enhance Osteogenic Differentiation in Dental Pulp Stem Cells via the Regulation of Wnt/β-Catenin Signaling.

Flavonoids of Cuscuta chinensis Enhance Osteogenic Differentiation in Dental Pulp Stem Cells via the Regulation of Wnt/β-Catenin Signaling.

Journal: Preventive nutrition and food science

Published: September 18, 2025

Development of a Novel Anti-Siglec-15 Antibody for Tumor Immunotherapy.

Development of a Novel Anti-Siglec-15 Antibody for Tumor Immunotherapy.

Journal: ImmunoTargets and therapy

Published: May 26, 2025

Bispecific Antibodies in Cancer Immunotherapy: Mechanisms, Challenges, and Emerging Therapeutic Strategies.

Bispecific Antibodies in Cancer Immunotherapy: Mechanisms, Challenges, and Emerging Therapeutic Strategies.

Journal: Genomics, proteomics & bioinformatics

Published: April 18, 2025

Correction: Therapeutic effect of fully human anti-Nrp-1 antibody on non-small cell lung cancer in vivo and in vitro.

Correction: Therapeutic effect of fully human anti-Nrp-1 antibody on non-small cell lung cancer in vivo and in vitro.

Journal: Cancer immunology, immunotherapy : CII

Published: April 11, 2025

The Role of Siglec-15 in Tumor Immunity: Mechanisms and Therapy.

The Role of Siglec-15 in Tumor Immunity: Mechanisms and Therapy.

Journal: Molecular cancer therapeutics

Published: March 24, 2025

Zebrafish xenografts in breast cancer research.

Zebrafish xenografts in breast cancer research.

Journal: Frontiers in immunology

Published: December 11, 2024

Endoplasmic reticulum stress on glioblastoma: Tumor growth promotion and immunosuppression.

Endoplasmic reticulum stress on glioblastoma: Tumor growth promotion and immunosuppression.

Journal: International immunopharmacology

Published: September 22, 2024

Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 blockade as a combined immunotherapy strategy for non-small cell lung cancer.

Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 blockade as a combined immunotherapy strategy for non-small cell lung cancer.

Journal: Frontiers in immunology

Published: August 26, 2024

Therapeutic effect of fully human anti-Nrp-1 antibody on non-small cell lung cancer in vivo and in vitro.

Therapeutic effect of fully human anti-Nrp-1 antibody on non-small cell lung cancer in vivo and in vitro.

Journal: Cancer immunology, immunotherapy : CII

Published: June 12, 2024

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma.

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma.

Journal: Genes

Published: November 09, 2022

Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade.

Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade.

Journal: Cytokine

Published: October 21, 2022

Characterization of a novel multidrug-resistant genomic island in Sphingobacterium spp. strains recovered from pleural fluid of lung cancer patients.

Characterization of a novel multidrug-resistant genomic island in Sphingobacterium spp. strains recovered from pleural fluid of lung cancer patients.

Journal: Journal of global antimicrobial resistance

Published: September 07, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026